tiprankstipranks

Gary Barnette Insider Profile

4 Followers
Gary Barnette, VP at Oncternal Therapeutics, holds 0.00 shares in Oncternal Therapeutics (Ticker: ONCT), holds 5.00K shares in Veru (Ticker: VERU). Most recently, Gary Barnette ― shares of Oncternal Therapeutics on ― for an estimated value of ―.
tipranks
Gary Barnette

Gary Barnette
Oncternal Therapeutics (ONCT)
VP

Ranked #19,790 out of 97,997 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+36.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5K
100.00%
0.00%
A breakdown of Gary Barnette's holdings

Insider Roles

Veru
(VERU)
CSO
Oncternal Therapeutics
(ONCT)
VP
Roles that Gary Barnette holds in companies

Most Profitable Insider Trade

Stock:
Veru
(VERU)
Rating:Informative Buy
Date:Dec 19, 2018 - Dec 19, 2019
Return:+104.40%
The most profitable trade made by Gary Barnette

Gary Barnette's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Oncternal Therapeutics
VP
$0.00
Veru
May 24, 2024
CSO
Informative Buy
6.65K
$4.68K
List of latest transactions for each holding click on a transaction to see Gary Barnette's performance on stock

Gary Barnette insider profile FAQ

What is the percentage of profitable transactions made by Gary Barnette?
The percentage of profitable transactions made by Gary Barnette is 67%.
    What is the average return per transaction made by Gary Barnette?
    The average return per transaction made by Gary Barnette is 36.40%.
      What stocks does Gary Barnette hold?
      Gary Barnette holds: ONCT, VERU stocks.
        What was Gary Barnette’s latest transaction?
        Gary Barnette latest transaction was an Uninformative Buy of ―.
          What was Gary Barnette's most profitable transaction?
          Gary Barnette’s most profitable transaction was an Informative Buy of VERU stock on December 19, 2018. The return on the trade was 104.40%.
            What is Gary Barnette's role in Oncternal Therapeutics?
            Gary Barnette's role in Oncternal Therapeutics is VP.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.